Theabrownin from dark tea may have the potential to treat insulin resistance

The effects of theabrownin (TB) from dark tea treatment on insulin resistance (IR).

Biophytis presented its phase 3 protocol in the treatment of sarcopenia – Biotech Investments

Biophytis / Key word(s): Miscellaneous Biophytis presented its phase 3 protocol in the treatment of sarcopenia 22-March-2024 / 07:01 CET/CEST Biophytis presented its phase 3

March 23, 2024

Phase 3 breast cancer failure leads to staff cuts, stock drop at G1 Therapeutics

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 25, 2024

The fundamentals of developing parenteral drug products – Pharmaceutical Technology

A target product profile (TPP) is a set of necessary attributes that the final drug product must have for the product to be used. It

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.